Drugs / TheraCal
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03214770 | Aug 2018 → Sep 2019 | dentin caries | Cairo University | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT06171776 | Jan 2023 → Jan 2024 | dental caries, exposure, dental pulp | Cairo University | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03119779 | Sep 2015 → Apr 2017 | dental caries | Cairo University | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT06020911 Comparator | Jan → Oct 2023 | pulp degeneration | Tanta University | Completed | No outcome recorded |
| Phase 4 | NCT05190783 Comparator | Mar 2019 → Aug 2021 | dental caries | Mansoura University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TheraCal | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05190783 ↗ |
| Modality | Other / unclassified | “light cured resin modified calcium silicate filled liner designed for use in direct and indirect pulp capping” NCT05190783 ↗ |
| Route | Other | “directly applied from the syringe container tip to pulp stump” NCT03119779 ↗ |